November 18, 2022
Life Sciences
  • The Food and Drug Administration (FDA) approved the first drug to prevent type 1 diabetes. Tzield, from ProventionBio and Sanofi, was approved to delay the onset of stage 3 type 1 diabetes in adults and children ages 8 and up who currently have stage 2 type 1 diabetes. The medication is thought to slow down the body’s attack on its own insulin-producing cells and thus give people more time before they become dependent on pharmaceutical insulin. The drug is given via intravenous infusion. (Press release here; Article here)